Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SERA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 46.44M
March 31, 2026 47.40M
December 31, 2025 39.20M
September 30, 2025 43.30M
June 30, 2025 40.16M
March 31, 2025 46.20M
December 31, 2024 46.24M
September 30, 2024 49.75M
June 30, 2024 50.94M
March 31, 2024 52.97M
December 31, 2023 49.08M
September 30, 2023 46.12M
Date Value
June 30, 2023 63.82M
March 31, 2023 70.79M
December 31, 2022 82.70M
September 30, 2022 88.78M
June 30, 2022 106.91M
March 31, 2022 107.55M
December 31, 2021 105.12M
September 30, 2021 119.98M
June 30, 2021 90.85M
March 31, 2021 60.02M
December 31, 2020 13.53M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 115.20M
BioRestorative Therapies, Inc. 3.592M
CareDx, Inc. 373.64M
Natera, Inc. 1.092B
Exagen, Inc. 24.59M